Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Decreases By 18.5%

SeaStar Medical Holding Corporation (NASDAQ:ICU) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 233,272 shares, a drop of 18.5% from the February 12th total of 286,335 shares. Based on an average daily volume of 43,336 shares, the short-interest ratio is presently 5.4 days. Approximately 6.2% of the shares of the stock are sold short. Approximately 6.2% of the shares of the stock are sold short. Based on an average daily volume of 43,336 shares, the short-interest ratio is presently 5.4 days.

Hedge Funds Weigh In On SeaStar Medical

Large investors have recently bought and sold shares of the company. Millennium Management LLC acquired a new stake in shares of SeaStar Medical during the third quarter valued at about $102,000. Jane Street Group LLC acquired a new position in shares of SeaStar Medical in the fourth quarter valued at approximately $30,000. XTX Topco Ltd increased its stake in shares of SeaStar Medical by 395.4% in the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock valued at $26,000 after buying an additional 48,674 shares during the period. Finally, Trinity Financial Advisors LLC raised its holdings in SeaStar Medical by 233.3% in the 3rd quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after buying an additional 35,000 shares during the last quarter. 1.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Weiss Ratings restated a “sell (e+)” rating on shares of SeaStar Medical in a research report on Thursday, January 22nd. Wall Street Zen raised SeaStar Medical to a “hold” rating in a research note on Saturday, January 10th. Finally, Maxim Group set a $6.00 target price on shares of SeaStar Medical in a report on Thursday, February 12th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, SeaStar Medical presently has an average rating of “Sell” and an average target price of $6.00.

SeaStar Medical Stock Performance

Shares of NASDAQ:ICU opened at $2.56 on Friday. SeaStar Medical has a 52-week low of $2.20 and a 52-week high of $25.70. The company has a market capitalization of $9.70 million, a PE ratio of -0.16 and a beta of -1.04. The company has a fifty day moving average of $2.50 and a 200-day moving average of $4.48.

SeaStar Medical Company Profile

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.